192 related articles for article (PubMed ID: 20179672)
1. Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
Hamed HA; Yacoub A; Park MA; Eulitt PJ; Dash R; Sarkar D; Dmitriev IP; Lesniak MS; Shah K; Grant S; Curiel DT; Fisher PB; Dent P
Mol Ther; 2010 Jun; 18(6):1130-42. PubMed ID: 20179672
[TBL] [Abstract][Full Text] [Related]
2. Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.
Eulitt PJ; Park MA; Hossein H; Cruikshanks N; Yang C; Dmitriev IP; Yacoub A; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Dec; 10(12):1290-305. PubMed ID: 20948318
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
[TBL] [Abstract][Full Text] [Related]
4. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins.
Hamed HA; Yacoub A; Park MA; Eulitt P; Sarkar D; Dimitrie IP; Chen CS; Grant S; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Apr; 9(7):526-36. PubMed ID: 20107314
[TBL] [Abstract][Full Text] [Related]
5. mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
Yacoub A; Mitchell C; Lebedeva IV; Sarkar D; Su ZZ; McKinstry R; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2003; 2(4):347-53. PubMed ID: 14508103
[TBL] [Abstract][Full Text] [Related]
6. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
[TBL] [Abstract][Full Text] [Related]
7. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
8. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
Yacoub A; Hamed H; Emdad L; Dos Santos W; Gupta P; Broaddus WC; Ramakrishnan V; Sarkar D; Shah K; Curiel DT; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2008 Jun; 7(6):917-33. PubMed ID: 18376144
[TBL] [Abstract][Full Text] [Related]
9. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling.
Yacoub A; Gupta P; Park MA; Rhamani M; Hamed H; Hanna D; Zhang G; Sarkar D; Lebedeva IV; Emdad L; Koumenis C; Curiel DT; Grant S; Fisher PB; Dent P
Mol Cancer Ther; 2008 Feb; 7(2):314-29. PubMed ID: 18281516
[TBL] [Abstract][Full Text] [Related]
10. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
Azab B; Dash R; Das SK; Bhutia SK; Shen XN; Quinn BA; Sarkar S; Wang XY; Hedvat M; Dmitriev IP; Curiel DT; Grant S; Dent P; Reed JC; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):2145-53. PubMed ID: 21780116
[TBL] [Abstract][Full Text] [Related]
11. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.
Dash R; Dmitriev I; Su ZZ; Bhutia SK; Azab B; Vozhilla N; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Gene Ther; 2010 Jul; 17(7):447-56. PubMed ID: 20150932
[TBL] [Abstract][Full Text] [Related]
12. Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells.
Hamed HA; Das SK; Sokhi UK; Park MA; Cruickshanks N; Archer K; Ogretmen B; Grant S; Sarkar D; Fisher PB; Dent P
Cancer Biol Ther; 2013 Nov; 14(11):1039-49. PubMed ID: 24025359
[TBL] [Abstract][Full Text] [Related]
13. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 mediates endogenous TLR2 activation and brain tumor regression.
Curtin JF; Liu N; Candolfi M; Xiong W; Assi H; Yagiz K; Edwards MR; Michelsen KS; Kroeger KM; Liu C; Muhammad AK; Clark MC; Arditi M; Comin-Anduix B; Ribas A; Lowenstein PR; Castro MG
PLoS Med; 2009 Jan; 6(1):e10. PubMed ID: 19143470
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
Yacoub A; Liu R; Park MA; Hamed HA; Dash R; Schramm DN; Sarkar D; Dimitriev IP; Bell JK; Grant S; Farrell NP; Curiel DT; Fisher PB; Dent P
Mol Pharmacol; 2010 Feb; 77(2):298-310. PubMed ID: 19910452
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
17. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
[TBL] [Abstract][Full Text] [Related]
18. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
Oida Y; Gopalan B; Miyahara R; Inoue S; Branch CD; Mhashilkar AM; Lin E; Bekele BN; Roth JA; Chada S; Ramesh R
Mol Cancer Ther; 2005 Feb; 4(2):291-304. PubMed ID: 15713900
[TBL] [Abstract][Full Text] [Related]
19. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
Park MA; Hamed HA; Mitchell C; Cruickshanks N; Dash R; Allegood J; Dmitriev IP; Tye G; Ogretmen B; Spiegel S; Yacoub A; Grant S; Curiel DT; Fisher PB; Dent P
Mol Pharmacol; 2011 Mar; 79(3):368-80. PubMed ID: 21119025
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
